New perspectives on the potential of tetrandrine in the treatment of non-small cell lung cancer: bioinformatics, Mendelian randomization study and experimental investigation-Reference-Cited by-同舟云学术

New perspectives on the potential of tetrandrine in the treatment of non-small cell lung cancer: bioinformatics, Mendelian randomization study and experimental investigation

Published:2024-01-04 Issue: Volume: Page:
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Luo Jihang¹²,Mo Xiaocong¹,Hu Di³,Li Yin¹,Xu Meng¹

Affiliation:

1. Department of Oncology, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China

2. Department of Infectious Diseases, Affiliated Hospital of Zunyi Medical University, Zunyi, China

3. Department of Neurology and Stroke Centre, The First Affiliated Hospital of Jinan University, Guangzhou, China

Publisher

Impact Journals, LLC

Reference53 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.;Bray;CA Cancer J Clin,2021

2. Lung cancer.;Heist;Lancet,2021

3. Practical Management of Oligometastatic Non-Small-Cell Lung Cancer.;Palma;J Clin Oncol,2022

4. Non-small cell lung cancer in China.;Zhou;Cancer Commun (Lond),2022

5. Challenge and countermeasures for EGFR targeted therapy in non-small cell lung cancer.;Dong;Biochim Biophys Acta Rev Cancer,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tetrandrine potentiates immunotherapy efficacy in non-small cell lung cancer: Modern wisdom of traditional Chinese medicine;PHARMACOL RES;2024

2. Tetrandrine activates STING/TBK1/IRF3 pathway to potentiate anti-PD-1 immunotherapy efficacy in non-small cell lung cancer;Pharmacological Research;2024-09